Sign in
MSCLF Stock Price, Chart, Stats & News
Satellos Bioscience Inc.
Save
Satellos Bioscience Inc. (MSCLF) does not currently pay a dividend.
96.62M
Market cap
2.43x
Current P/E
–
Forward P/E
MSCLF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug. This therapeutic seeks to rectify muscle stem cell polarity, which in turn is intended to restore the body's natural processes for muscle repair and regeneration.
Similar securities
Based on sector and market capitalization
Report issue